Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 09-2012 | 06-2012 | 03-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1 | 0 | 10 | 60 | 0 |
| Receivables | 1 | 0 | 0 | 0 | 3 |
| Other current assets | 0 | 0 | 30 | 50 | 17 |
| TOTAL | $2 | $0 | $40 | $110 | $20 |
| Non-Current Assets | |||||
| PPE Net | 37 | N/A | N/A | 150 | 150 |
| Intangibles | 193 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 200 | 210 | 210 |
| TOTAL | $230 | $N/A | $200 | $360 | $360 |
| Total Assets | $232 | $0 | $300 | $370 | $290 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 0 | 0 | 20 | 10 |
| Accrued Expenses | N/A | 0 | 80 | 170 | 150 |
| Other current liabilities | N/A | 0 | 740 | 600 | 640 |
| TOTAL | $N/A | $0 | $1,940 | $1,820 | $1,670 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,112 | 0 | 0 | 0 | 0 |
| TOTAL | $2,112 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,112 | $0 | $1,940 | $1,820 | $1,670 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 54,540 | N/A |
| Common Shares | 55 | 0 | 50 | 50 | 10 |
| Retained earnings | -30,550 | 0 | -30,310 | -30,120 | -29,770 |
| Other shareholders' equity | 0 | 0 | 10 | 10 | 10 |
| TOTAL | $-1,880 | $0 | $-1,640 | $-1,450 | $-1,380 |
| Total Liabilities And Equity | $232 | $0 | $300 | $370 | $290 |